The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
November 23rd 2024
A recent study suggests ketamine can significantly improve symptoms of PTSD and OCD—but this is based on a review of an insufficient number of randomized controlled trials.
November 22nd 2024
November 14th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Your Judgments are Hurting Your Patients
December 3rd 2015With the amount of information we are hit with day in and day out, our minds need a way of quickly triaging it. This is what stereotyping does. But let's not confuse stereotyping with prejudice. The latter is negative and the former doesn't have to be.
Depression Increases Risk of Mortality Fivefold for Heart Failure Patients
Depression affects 20-40 percent of heart failure patients and is often linked to loss of motivation/ interest/confidence, lower quality of life, sleep disturbances, and changes in appetite with related weight changes.
A New Approach to Assessing Risk of Violence
December 2nd 2015Researchers from Queen Mary University of London have called for the abandonment of standard approaches for investigating the risk of violence among psychiatric patients and prisoners in all future studies due to findings that show these approaches to be inaccurate.
Morphine Regulator May Reduce Pain-Kill Abuse Risk
November 16th 2015Researchers appear to have identified a specific molecule that controls morphine receptor signaling in a small group of brain cells. The particular regulator of G protein signaling protein is called RGS7 and has been identified as a novel regulator of the μ-opioid receptor, which morphine acts upon to mediate its euphoric and analgesic effects.
Depression May Double Risk of Stroke
Depression over long periods of time may double the risk of stroke in adults, according to a study that assessed the health information of more than 16,000 adults over 50 years of age in order to determine if there is a link between stroke and depressive symptoms.
Depression and Mood Influence Pain in Rheumatoid Arthritis Patients
Researchers report that in patients with rheumatoid arthritis (RA), greater positive mood throughout daily life was linked to less pain and fewer RA-related restrictions, while negative mood was linked to an increase in RA-related restrictions.
Testosterone Levels, Finger Length, and Fidelity
Since the discovery that the relative length of the index and ring fingers may reflect fetal testosterone exposure, researchers have spent a lot of time trying to find correlations between digit ratios and medical outcomes, questionnaire answers, and a host of other things.
Treating Substance Abuse and Addiction in HIV Patients
November 3rd 2015A program that integrated addiction treatment into primary care for patients with, or at risk for, HIV appears to successfully engage and treat patients with substance dependence. Developed by researchers at Boston Medical Center, the program was shown to reduce substance dependence and encourage engagement in treatment.
Study Will Assess Antidepressant for Treating Knee Osteoarthritis
A New Zealand study announced in Trials will examine whether the antidepressant nortriptyline can safely and effectively treat knee osteoarthritis. The medication is inexpensive and readily available, and it is well-tolerated in patients treated for depression.